Autologous peripheral blood progenitor cells are a potential source of parvovirus B19 infection

被引:15
作者
Arnold, DM
Neame, PB
Meyer, RM
Soamboonsrup, P
Luinstra, KE
O'Hoski, P
Garner, J
Foley, R
机构
[1] Hamilton Ctr, Canadian Blood Serv, Hamilton, ON, Canada
[2] McMaster Univ, Dept Med, Hamilton, ON, Canada
[3] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada
[4] Hamilton Hlth Sci, Dept Lab Med, Hamilton, ON, Canada
[5] Juravinski Canc Ctr, Hamilton, ON, Canada
[6] St Josephs Hosp, Dept Virol, Hamilton, ON, Canada
关键词
D O I
10.1111/j.1537-2995.2005.04267.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Parvovirus B19 is a cause of delayed red blood cell (RBC) engraftment after marrow transplantation (BMT). The diagnosis of parvovirus infection requires serologic and DNA testing in the context of clinical disease and characteristic marrow morphologic findings; however, the source of infection is often difficult to determine. STUDY DESIGN AND METHODS: Investigation of a case of delayed RBC engraftment and pure RBC aplasia (PRCA) occurring 3 months after autologous peripheral blood progenitor cell (PBPC) transplantation in a patient with high-risk diffuse large B-cell lymphoma. DNA testing of serum and of a sample of cryopreserved PBPCs was performed. RESULTS: Marrow morphology showed a maturational arrest of erythroid cells with giant proerythroblasts. Polymerase chain reaction and nucleic acid hybridization confirmed the presence of parvovirus DNA in the serum and in a sample of sequestered PBPCs saved at the time of PBPC harvest. PRCA resolved after the administration of intravenous immune globulin. CONCLUSION: Autologous PBPCs are a potential source of parvovirus infection, which may cause significant disease after autologous BMT.
引用
收藏
页码:394 / 398
页数:5
相关论文
共 27 条
[1]   Clinical relevance of parvovirus B19 as a cause of anemia in patients with human immunodeficiency virus infection [J].
Abkowitz, JL ;
Brown, KE ;
Wood, RW ;
Kovach, NL ;
Green, SW ;
Young, NS .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (01) :269-273
[2]   HUMAN PARVOVIRUS-B19 INFECTION IN BONE-MARROW TRANSPLANTATION PATIENTS [J].
AZZI, A ;
FANCI, R ;
CIAPPI, S ;
ZAKRZEWSKA, K ;
BOSI, A .
AMERICAN JOURNAL OF HEMATOLOGY, 1993, 44 (03) :207-209
[3]  
Brown Kevin E., 2001, Transfusion (Bethesda), V41, P130, DOI 10.1046/j.1537-2995.2001.41010130.x
[4]  
CARBONE PP, 1971, CANCER RES, V31, P1860
[5]   B19 virus infection in renal transplant recipients [J].
Cavallo, R ;
Merlino, C ;
Re, D ;
Bollero, C ;
Bergallo, M ;
Lembo, D ;
Musso, T ;
Leonardi, G ;
Segoloni, GP ;
Ponzi, AN .
JOURNAL OF CLINICAL VIROLOGY, 2003, 26 (03) :361-368
[6]   Chronic anemia due to parvovirus B19 infection in a bone marrow transplant patient after platelet transfusion [J].
Cohen, BJ ;
Beard, S ;
Knowles, WA ;
Ellis, JS ;
Joske, D ;
Goldman, JM ;
Hewitt, P ;
Ward, KN .
TRANSFUSION, 1997, 37 (09) :947-952
[7]  
*DEP HHS FOOD DRUG, 2001, OBRR CBER FDA WORKSH
[8]   High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma [J].
Gianni, AM ;
Bregni, M ;
Siena, S ;
Brambilla, C ;
DiNicola, M ;
Lombardi, F ;
Gandola, L ;
Tarella, C ;
Pileri, A ;
Ravagnani, F ;
Valagussa, P ;
Bonadonna, G ;
Stern, AC ;
Magni, M ;
Caracciolo, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (18) :1290-1297
[9]   Life-threatening human parvovirus B19 infection transmitted by intravenous immune globulin [J].
Hayakawa, F ;
Imada, K ;
Towatari, M ;
Saito, H .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (04) :1187-1189
[10]   Pure red cell aplasia associated with parvovirus B19 infection occurring late after allogeneic bone marrow transplantation [J].
Hayes-Lattin, B ;
Seipel, TJ ;
Gatter, K ;
Heinrich, MC ;
Maziarz, RT .
AMERICAN JOURNAL OF HEMATOLOGY, 2004, 75 (03) :142-145